Status:

COMPLETED

Inhaled Bicarbonate Therapy in Cystic Fibrosis

Lead Sponsor:

University of Pittsburgh

Collaborating Sponsors:

Cystic Fibrosis Foundation

Conditions:

Cystic Fibrosis

Eligibility:

All Genders

12+ years

Phase:

PHASE1

Brief Summary

The purpose of this study is to see if inhaled bicarbonate will increase the ability to cough up mucus in a person with cystic fibrosis.

Detailed Description

There is evidence that people with CF may have differences in the liquid that lines the surface of their lungs from people without CF. There are two things that are known to be different. One is calle...

Eligibility Criteria

Inclusion

  • age 12 or older
  • Forced expiratory volume in one second (FEV1) \>40% predicted
  • Ability to expectorate sputum

Exclusion

  • pregnancy
  • pulmonary exacerbation or initiation of inhaled or oral antibiotics, steroids, or aerosol treatments within the last four weeks
  • oxygen saturation \<92%, or requirement for supplemental oxygen

Key Trial Info

Start Date :

March 1 2002

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2006

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT00177645

Start Date

March 1 2002

End Date

December 1 2006

Last Update

September 7 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Children's Hospital of Pittsburgh

Pittsburgh, Pennsylvania, United States, 15213

Inhaled Bicarbonate Therapy in Cystic Fibrosis | DecenTrialz